Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

Scientists have found that a mutation tied to Alzheimer’s disrupts the production and quality of exosomes—tiny cell-made ...

In an effort to reveal the inner workings of a protein that serves as a cell's damage detection system, scientists at Johns ...

Cyanobacteria, also known as blue-green algae, occur worldwide in many varieties, including in single-cell form and in chains ...

Bitmain, whose AntPool controlled a massive chunk of hashrate, was a major holdout in SegWit’s activation, as co-founder ...

After fertilization, embryos race through rapid cell divisions before slowing down to build specialized cells that will carry ...

With aging, the intestine gradually loses its ability to regenerate after damage. An international research team involving ...

New evidence shows how the Epstein-Barr virus can hide in B cells and drive the core autoimmune response in lupus, pointing ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial ...

First publicly listed company to actively investigate psilocybin’s potential impact on longevity NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or ...